logo
Gisborne's top vineyard pruners put to the test in annual competition

Gisborne's top vineyard pruners put to the test in annual competition

NZ Herald21-07-2025
Vineyard pruners sorted out the best from the rest in a day of skill, teamwork and friendly rivalry at the annual Gisborne Silver Secateur Awards held at Ashwood Estate/Makaraka racecourse.
The event attracted more than 45 entrants from vineyards across the region.
Organised and co-ordinated by LeaderBrand viticulture
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Hims & Hers Q2 2025: What You Need to Know Ahead of Earnings
Hims & Hers Q2 2025: What You Need to Know Ahead of Earnings

Yahoo

time12 minutes ago

  • Yahoo

Hims & Hers Q2 2025: What You Need to Know Ahead of Earnings

Hims & Hers Health (NYSE:HIMS) reports Q2 2025 earnings after U.S. markets close on Monday, August 4. Analysts expect revenue of around $552 million, up 75% YoY, and adjusted EPS near $0.15, roughly up 15% YoY. Despite the volatility, shares are up 154% YTD, pushing the forward P/E to roughly 57. Subscriber growth remains the core engine investors care about. Subscribers increased 38% in Q1, reaching 2.4 million. Weight-loss GLP-1 offerings are a swing factor, but Novo Nordisk (NYSE:NVO) ended its partnership on 23 Jun 2025, citing illegal mass compounding and deceptive marketing, which sent Hims down 30%. Analysts estimate that up to half of Hims' projected weight-loss revenue could be at risk. Investors need clarity on FDA scrutiny, formulary access, and whether compounded semaglutide margins can hold. Marketing spend, revenue per average user, and progress on the ZAVA integration will also be closely watched. Management guides FY25 revenue of $2.32.4 billion and low-teens EBITDA margins. Any uplift to those guides or clean regulatory commentary could keep momentum intact. But with valuation stretched, even a top-line beat may disappoint if churn ticks up or compliance costs bite. Q2 will test whether the telehealth disrupter can scale responsibly before regulators step in. This article first appeared on GuruFocus. Sign in to access your portfolio

AI Glasses Could Replace Smartphones, Zuckerberg Says
AI Glasses Could Replace Smartphones, Zuckerberg Says

Yahoo

time12 minutes ago

  • Yahoo

AI Glasses Could Replace Smartphones, Zuckerberg Says

Meta Platforms (NASDAQ:META) is pushing a post-iPhone era with AI-powered glasses, recasting the smartphone as yesterday's interface. Investors are weighing in whether Zuckerberg's personal superintelligence vision can move from manifesto to mainstream. Warning! GuruFocus has detected 5 Warning Sign with META. He says the glasses will know users deeply, understand goals and help achieve them, and the company is piling on AI talent to build standalone versions that no longer need a phone. Right now the Ray-Ban smartglasses still lean on smartphones, but the roadmap is toward independent multimodal displays. Apple is defending the iPhone's role, while rivals are racing too: Amazon bought wearable startup Bee and Sam Altman is teaming with Jony Ive on a secret AI device. The shift in tone at Meta, from past hardware misses to a more urgent, existential pitch, is meant to turn skepticism into a narrative of necessity. This article first appeared on GuruFocus. Sign in to access your portfolio

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store